PriorixTM

also known as Priorix

Also used as a comparator or background therapy in 1 trial

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 3	NCT00751348 Comparator	Oct 2008 → May 2010	measles, mumps infectious disease, rubella, varicella zoster infection	GlaxoSmithKline	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	PriorixTM	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00751348 ↗
Known as	Priorix	“who received one dose of Priorix™ vaccine together with one dose of Varilrix™ vaccine at Day 0, administered subcutaneously in the deltoid regions of the left or right upper...” NCT00751348 ↗
Modality	Vaccine	“Priorix™ vaccine” NCT00751348 ↗